JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cook, D. L.
Right arrow Articles by Cusic, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cook, D. L.
Right arrow Articles by Cusic, J. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 120, Issue 3, 269-275, 1957
Copyright © 1957 by American Society for Pharmacology and Experimental Therapeutics


RELATION OF PERIPHERAL VASODILATOR ACTIVITY TO CHEMICAL STRUCTURE OF 1,2,3,4-TETRAHYDROISOQUINPLINE DERIVATIVES

Donald L. Cook 1, Coleta A. Lawler 1, and John W. Cusic 1

1 The Divisions of Biological Research and Chemical Research, G. D. Searle & Co., Chicago, Illinois

Peripheral vasodilator activity of a series of 1,2,3,4-tetrahydroisoquinoline (THIQ) derivatives was studied in the dog. The series included four chemical types: aliphatic, heterocydic, ester and ether. Activity was found in all types. The most active compound was a heterocycic derivative, N-beta-hydroxyethyl-THIQ-2-thenyl ether, which was forty-five times as active as the parent compound (THIQ). This compound was also found to possess potent adrenergic blocking activity.

Submitted on January 30, 1957







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1957 by the American Society for Pharmacology and Experimental Therapeutics.